| Literature DB >> 32691535 |
Karolina Dorobisz1, Tadeusz Dorobisz2, Tomasz Zatoński1.
Abstract
INTRODUCTION: Vertigo and balance disorders are a significant clinical problem, especially in elderly patients. The narrowing of cranial vessels may be asymptomatic or produce neurological symptoms. Very often nonspecific signs of ischemia occur, such as headache, vertigo, or dizziness.Entities:
Keywords: balance system; cranial artery stenosis; stroke; vertigo
Mesh:
Year: 2020 PMID: 32691535 PMCID: PMC7507416 DOI: 10.1002/brb3.1695
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
The results of labyrinth tests (ENG) obtained in the study group compared with the control group
|
Total
|
Test group
|
Control group
|
| ||||
|---|---|---|---|---|---|---|---|
| Spontaneous nystagmus: |
| % |
| % |
| % | |
| No | 75 | 78.9% | 43 | 68.2% | 32 | 100.0% |
|
| Yes | 20 | 21.1% | 20 | 31.8% | 0 | 0.0% | |
| 44°C SPV [°/s] – RE—right ear | |||||||
|
| 5.27 ± 3.68 | 5.00 ± 4.36 | 5.81 ± 1.61 |
| |||
|
| 5.5 (3.4; 6.6) | 4.3 (2.1; 6.5) | 6.2 (4.8; 7.2) | ||||
| 44°C SPV [°/s] – LE—left ear | |||||||
|
| −5.51 ± 3.89 | −5.49 ± 4.42 | −5.56 ± 2.64 | 0.230 | |||
|
| −4.8 (−7.4; −3.2) | −4.3 (−8.1; −2.7) | −4.9 (−6.3; −3.9) | ||||
| |UP| versus |UL| (test Wilcoxon) |
|
|
| × | |||
| 30°C SPV [°/s] – RE | |||||||
|
| −6.20 ± 3.17 | −5.99 ± 3.38 | −6.62 ± 2.72 | 0.180 | |||
|
| −5.8 (−8.1; −3.5) | −4.8 (−8.2; −3.1) | −5.9 (−7.5; −4.8) | ||||
| 30°C SPV [°/s] – LE | |||||||
|
| 5.73 ± 3.76 | 5.89 ± 4.12 | 5.41 ± 2.95 | 0.810 | |||
|
| 4.7 (2.9; 8.4) | 4.9 (2.2; 8.9) | 4.3 (3.5; 7.5) | ||||
| |RE| versus |LE| |
|
|
| × | |||
| Positional nystagmus: |
| % |
| % |
| % |
|
| Absence | 62 | 65.3% | 30 | 47.6% | 32 | 100.0% |
|
| Nylen 1 | 18 | 18.9% | 18 | 28.6% | 0 | 0.0% | |
| Nylen 2 | 1 | 1.1% | 1 | 1.6% | 0 | 0.0% | |
| Nylen 3 | 14 | 14.7% | 14 | 22.2% | 0 | 0.0% | |
| Optokinetic nystagmus: |
| % |
| % |
| % | |
| Normal | 61 | 64.2% | 31 | 49.2% | 30 | 93.8% |
|
| Abnormal | 34 | 35.8% | 32 | 50.8% | 2 | 6.3% | |
| Pendulum test: |
| % |
| % |
| % | |
| Normal | 69 | 72.6% | 39 | 61.9% | 30 | 93.8% |
|
| Abnormal. type I | 24 | 25.3% | 22 | 34.9% | 2 | 6.3% | |
| Abnormal. type II | 2 | 2.1% | 2 | 3.2% | 0 | 0.0% | |
| Dysmetry: |
| % |
| % |
| % | |
| No | 94 | 98.9% | 62 | 98.4% | 32 | 100.0% | 1.000 |
| Yes | 1 | 1.1% | 1 | 1.6% | 0 | 0.0% | |
| Square waves: |
| % |
| % |
| % | |
| No | 76 | 80.0% | 44 | 69.8% | 32 | 100.0% |
|
| Yes | 19 | 20.0% | 19 | 30.2% | 0 | 0.0% | |
| Dysrhythmia: |
| % |
| % |
| % | |
| No | 92 | 96.8% | 60 | 95.2% | 32 | 100.0% | 0.548 |
| Yes | 3 | 3.2% | 3 | 4.8% | 0 | 0.0% | |
Significance means that p is less than or equal to .05.
The results of posturographic tests obtained in the study group compared with the control group (number and proportion of abnormal results)
| Test |
Test group
|
Control group
|
| ||
|---|---|---|---|---|---|
|
| % |
| % | ||
| 1. Test Weight Bearing Squat (WBS) | |||||
| Normal results | 55 | 87.3% | 32 | 100.0% | 0.109 |
| Abnormal results‐left leg | 5 | 7.9% | 0 | 0.0% | |
| Abnormal results‐right leg | 3 | 4.8% | 0 | 0.0% | |
| Abnormal results: | |||||
| Test MCTSIB FIRM EO‐eyes open | 3 | 4.8% | 0 | 0.0% | 0.548 |
| Test MCTSIB FIRM EC‐eyes closed | 38 | 60.3% | 1 | 3.1% |
|
| Test MCTSIB FOAM EO | 19 | 30.2% | 3 | 9.4% |
|
| Test MCTSIB FOAM EC | 49 | 77.8% | 9 | 28.1% |
|
| Test UL L‐EO | 5 | 7.9% | 0 | 0.0% | 0.164 |
| Test UL R‐EO | 8 | 12.7% | 0 | 0.0% |
|
| Test UL L‐EC | 39 | 61.9% | 5 | 15.6% |
|
| Test UL R‐EC | 41 | 65.1% | 6 | 18.8% |
|
| Test LOS RT‐reaction time, forward | 3 | 4.8% | 0 | 0.0% | 0.548 |
| Test LOS RT backward | 7 | 11.1% | 0 | 0.0% | 0.091 |
| Test LOS RT right | 7 | 11.1% | 0 | 0.0% | 0.091 |
| Test LOS RT left | 4 | 6.3% | 0 | 0.0% | 0.297 |
| Test LOS MVL (°/s) forward | 2 | 3.2% | 0 | 0.0% | 0.548 |
| Test LOS MVL (°/s) backward | 15 | 23.8% | 0 | 0.0% |
|
| Test LOS MVL (°/s) right | 4 | 6.3% | 0 | 0.0% | 0.297 |
| Test LOS MVL (°/s) left | 7 | 11.1% | 0 | 0.0% | 0.091 |
| Test LOS DCL (%) forward | 7 | 11.1% | 0 | 0.0% | 0.091 |
| Test LOS DCL (%) backward | 33 | 52.4% | 2 | 6.2% |
|
| Test LOS DCL (%) right | 19 | 30.2% | 0 | 0.0% |
|
| Test LOS DCL (%) left | 19 | 30.2% | 0 | 0.0% |
|
| Test LOS EPE (%) forward | 13 | 20.6% | 0 | 0.0% |
|
| Test LOS EPE (%) backward | 27 | 42.9% | 0 | 0.0% |
|
| Test LOS EPE (%) right | 16 | 25.4% | 0 | 0.0% |
|
| Test LOS EPE (%) left | 17 | 27.0% | 0 | 0.0% |
|
| Test LOS MXE (%) forward | 16 | 25.4% | 0 | 0.0% |
|
| Test LOS MXE (%) backward | 34 | 54.0% | 3 | 9.4% |
|
| Test LOS MXE (%) right | 20 | 31.7% | 1 | 3.1% |
|
| Test LOS MXE (%) left | 22 | 34.9% | 1 | 3.1% |
|
| Left–right | |||||
| Test RWS 1/S (°/s) | 3 | 4.8% | 0 | 0.0% | 0.548 |
| Test RWS 2/S (°/s) | 6 | 9.5% | 0 | 0.0% | 0.093 |
| Test RWS 3/S (°/s) | 16 | 25.4% | 0 | 0.0% |
|
| Test RWS DCL 1/S (%) | 4 | 6.3% | 0 | 0.0% | 0.297 |
| Test RWS DCL 2/S (%) | 18 | 28.6% | 2 | 6.2% |
|
| Test RWS DCL 3/S (%) | 30 | 47.6% | 5 | 15.6% |
|
| Forward–backward | |||||
| Test RWS 1/S (°/s) | 4 | 6.3% | 0 | 0.0% | 0.297 |
| Test RWS 2/S (°/s) | 10 | 15.9% | 0 | 0.0% |
|
| Test RWS 3/S (°/s) | 18 | 28.6% | 1 | 3.1% |
|
| Test RWS DCL 1/S (%) | 14 | 22.2% | 0 | 0.0% |
|
| Test RWS DCL 2/S (%) | 36 | 57.1% | 2 | 6.2% |
|
| Test RWS DCL 3/S (%) | 44 | 69.8% | 7 | 21.9% |
|
Significance means that p is less than or equal to .05.
The comparison of posturography results obtained in patients from the study group with and without dizziness (number and proportion of abnormal results)
| Test |
Patients without vertigo
|
Patients with vertigo
|
| ||
|---|---|---|---|---|---|
|
| % |
| % | ||
| 1. WBS | |||||
| Normal | 17 | 94.4% | 38 | 84.4% | 0.466 |
| Abnormal results‐left leg | 1 | 5.6% | 4 | 8.9% | |
| Abnormal result‐right leg | 0 | 0.0% | 3 | 6.7% | |
| Abnormal results: | |||||
| Test mCTSIB FIRM EO | 28 | 62.2% | 16 | 88.9% | 1.000 |
| Test mCTSIB FIRM EC | 2 | 11.1% | 36 | 80.0% |
|
| Test mCTSIB FOAM EO | 2 | 11.1% | 17 | 37.8% | 0.066 |
| Test mCTSIB FOAM EC | 9 | 50.0% | 40 | 88.9% |
|
| Test US L‐EO | 1 | 5.6% | 4 | 8.9% | 1.000 |
| Test US R‐EO | 2 | 11.1% | 6 | 13.3% | 1.000 |
| Test US L‐EC | 4 | 22.2% | 35 | 77.8% |
|
| Test US R‐EC | 5 | 27.8% | 36 | 80.0% |
|
| Test LOS forward | 0 | 0.0% | 3 | 6.7% | 0.551 |
| Test LOS backward | 1 | 5.6% | 6 | 13.3% | 0.347 |
| Test LOS right | 1 | 5.6% | 6 | 13.3% | 0.662 |
| Test LOS left | 0 | 0.0% | 4 | 8.9% | 0.317 |
| Test LOS MVL (°/s) forward | 0 | 0.0% | 2 | 4.4% | 1.000 |
| Test LOS MVL (°/s) backward | 2 | 11.1% | 13 | 28.9% | 0.195 |
| Test LOS MVL (°/s) right | 0 | 0.0% | 4 | 8.9% | 0.317 |
| Test LOS MVL (°/s) left | 1 | 5.6% | 6 | 13.3% | 0.662 |
| Test LOS DCL (%) forward | 1 | 5.6% | 6 | 13.3% | 0.662 |
| Test LOS DCL (%) backward | 6 | 33.3% | 27 | 60.0% | 0.102 |
| Test LOS DCL (%) right | 2 | 11.1% | 17 | 37.8% | 0.066 |
| Test LOS DCL (%) left | 2 | 11.1% | 17 | 37.8% | 0.069 |
| Test LOS EPE (%) forward | 1 | 5.6% | 12 | 26.7% | 0.087 |
| Test LOS EPE (%) backward | 3 | 16.7% | 24 | 53.3% |
|
| Test LOS EPE (%) right | 1 | 5.6% | 15 | 33.3% |
|
| Test LOS EPE (%) left | 2 | 11.1% | 15 | 33.3% | 0.115 |
| Test LOS MXE (%) forward | 1 | 5.6% | 15 | 33.3% |
|
| Test LOS MXE (%) backward | 5 | 27.8% | 29 | 64.4% |
|
| Test LOS MXE (%) right | 1 | 5.6% | 19 | 42.2% |
|
| Test LOS MXE (%) left | 2 | 11.1% | 20 | 44.4% |
|
| Left–right | |||||
| Test RWS 1/S (°/s) | 1 | 5.6% | 2 | 4.4% | 1.000 |
| Test RWS 2/S (°/s) | 1 | 5.6% | 5 | 11.1% | 0.664 |
| Test RWS 3/S (°/s) | 1 | 5.6% | 15 | 33.3% |
|
| Test RWS DCL 1/S (%) | 1 | 5.6% | 3 | 6.7% | 1.000 |
| Test RWS DCL 2/S (%) | 1 | 5.6% | 17 | 37.8% |
|
| Test RWS DCL 3/S (%) | 3 | 16.7% | 27 | 60.0% |
|
| Forward–backward | |||||
| Test RWS 1/S (°/s) | 1 | 5.6% | 3 | 6.7% | 1.000 |
| Test RWS 2/S (°/s) | 1 | 5.6% | 9 | 20.0% | 0.257 |
| Test RWS 3/S (°/s) | 1 | 5.6% | 17 | 37.8% |
|
| Test RWS DCL 1/S (%) | 1 | 5.6% | 13 | 28.9% | 0.051 |
| Test RWS DCL 2/S (%) | 5 | 27.8% | 31 | 68.9% |
|
| Test RWS DCL 3/S (%) | 7 | 38.9% | 37 | 82.2% |
|
Significance means that p is less than or equal to .05.